Original Literature | Model OverView |
---|---|
Publication
Title
New insights into NF-kappaB regulation and function.
Affiliation
Department of Immunology, MD Anderson Cancer Center, University of Texas,Houston, TX 77030, USA. ssun@mdanderson.org
Abstract
NF-kappaB (nuclear factor-kappaB) transcription factors have multiple criticalroles in the regulation of immune responses. In unstimulated cells, NF-kappaBproteins are sequestered in the cytoplasm by IkappaB inhibitory proteins.Various immune stimuli induce the IkappaB kinase (IKK) to phosphorylateIkappaBs, triggering their ubiquitination and proteasomal degradation, whichpermits nuclear translocation of associated NF-kappaB subunits and activation ofNF-kappaB target genes. Recent studies have highlighted the importance ofdynamic ubiquitination-deubiquitination events in regulating this canonicalNF-kappaB signaling pathway. Ubiquitination additionally plays critical roles inactivation of the noncanonical pathway that regulates NF-kappaB viasignal-induced processing of NF-kappaB2 p100. New research has also identifiedseveral novel regulatory proteins that control the transcriptional activity ofnuclear NF-kappaB.
PMID
18775672
|
Entity
Process
RIP1
--
MO000000065
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m63
10
infinite
0
InterPro | IPR000198 |
TRANSPATH | MO000000065 |
--
c-Rel
--
MO000000192
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m165
10
infinite
0
TRANSPATH | MO000000192 |
--
p50:p50:p105{p}
--
MO000000199
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m171
10
infinite
0
TRANSPATH | MO000000199 |
--
NIK
--
MO000000203
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m174
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000203 |
--
TRAF2
--
MO000000209
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m180
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000209 |
--
IKK
--
MO000000210
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m181
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
IkappaB-alpha
--
MO000000233
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m199
10
infinite
0
InterPro | IPR002110 |
TRANSPATH | MO000000233 |
--
Bcl-3{ub}
--
MO000000238
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m204
10
infinite
0
InterPro | IPR002110 |
TRANSPATH | MO000000238 |
--
p50:RelA-p65:IkappaB-alpha{p}
--
MO000000254
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m208
10
infinite
0
TRANSPATH | MO000000254 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
A20
--
MO000016591
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1585
10
infinite
0
InterPro | IPR002653 |
TRANSPATH | MO000016591 |
--
p50:RelA-p65
--
MO000016632
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1617
10
infinite
0
TRANSPATH | MO000016632 |
--
TGFbeta1
--
MO000017443
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2269
10
infinite
0
InterPro | IPR002400 |
TRANSPATH | MO000017443 |
--
Smad4{active}
--
MO000017458
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2280
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000017458 |
--
PIAS1
--
MO000017700
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2460
10
infinite
0
InterPro | IPR004181 |
TRANSPATH | MO000017700 |
--
HDACs
--
MO000023571
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m7346
10
infinite
0
TRANSPATH | MO000023571 |
--
Ubc13:Uev1
--
MO000038325
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m16540
10
infinite
0
TRANSPATH | MO000038325 |
--
p50:RelA-p65:IkappaB-alpha
--
MO000038724
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16910
10
infinite
0
TRANSPATH | MO000038724 |
--
CYLD
--
MO000041169
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19042
10
infinite
0
TRANSPATH | MO000041169 |
--
RPS3
--
MO000069621
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m44464
10
infinite
0
TRANSPATH | MO000069621 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
p50:RelA-p65{p}
--
e10
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m10
10
infinite
0
TRANSPATH | MO000016632 |
--
ABIN-3:k63 ubiquitinated protein
--
e100
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m102
0
infinite
0
--
A20:TAX1BP1:RIP1{ub}
--
e101
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m103
0
infinite
0
--
A20:TAX1BP1:RIP1
--
e102
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m104
0
infinite
0
--
A20:TAX1BP1:TRAF6{ub]
--
e103
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m105
0
infinite
0
--
SCF ubiquitin E3 ligase
--
e104
cso30:c:Protein
cso30:i:CC_Cell
--
--
csml-variable:Double
m106
0
infinite
0
--
A20:TAX1BP1:TRAF6
--
e105
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m107
0
infinite
0
--
synthetic c-IAP antagonist
--
e106
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m108
0
infinite
0
--
c-IAP1{ub}
--
e107
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m109
0
infinite
0
--
c-IAP2{ub}
--
e108
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m110
0
infinite
0
--
p50:p50:HDACs
--
e109
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m111
0
infinite
0
--
IL-1:IL-1R
--
e11
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
p52:p52:HDACs
--
e111
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m113
0
infinite
0
--
MSK2
--
e112
cso30:c:Protein
cso30:i:CC_Cell_WithoutCellWall_
--
--
csml-variable:Double
m114
0
infinite
0
--
p300/CBP
--
e113
cso30:c:Protein
cso30:i:CC_Cell_WithoutCellWall_
--
csml-variable:Double
m115
0
infinite
0
--
p300/CBP{p}
--
e114
cso30:c:Protein
cso30:i:CC_Cell_WithoutCellWall_
--
csml-variable:Double
m116
0
infinite
0
--
p50:RelaA{p}:p300/CBP{p}
--
e115
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m117
0
infinite
0
--
p50:RelaA{p}{Ac}:p300/CBP{p}
--
e116
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m118
0
infinite
0
--
CDK1:CyclinT1
--
e117
cso30:c:Complex
cso30:i:CC_Cell_WithoutCellWall_
--
--
csml-variable:Double
m119
0
infinite
0
--
p50:RelaA{p}{Ac}:p300/CBP{p}:CDK1:Cyclin T1
--
e118
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m120
0
infinite
0
--
TNF
--
e12
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
p50:RelA-p65{p}
--
e122
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m124
10
infinite
0
TRANSPATH | MO000016632 |
--
IKappaB-alpha
--
e124
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m126
0
infinite
0
--
p50:RelA-p65{p}{ub}
--
e125
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m127
10
infinite
0
TRANSPATH | MO000016632 |
--
PDLIM2
--
e126
cso30:c:Protein
cso30:i:CC_Cell
--
--
csml-variable:Double
m128
0
infinite
0
--
proteosome degradants
--
e127
cso30:c:EntityBiological
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m129
0
infinite
0
--
c-Rel{ub}
--
e128
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m130
0
infinite
0
--
P-TEFB
--
e129
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m131
0
infinite
0
--
TNFR
--
e13
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m13
0
infinite
0
--
:RelA-p65{p}:P-TEFB
--
e130
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m132
0
infinite
0
--
IL-8
--
e131
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m133
0
infinite
0
--
Smad3{active}
--
e132
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m134
10
infinite
0
TRANSPATH | MO000017450 |
--
PKA{active}
--
e134
cso30:c:Protein
cso30:i:CC_Cell_WithoutCellWall_
--
csml-variable:Double
m136
0
infinite
0
--
p300/CBP{active}
--
e135
cso30:c:Protein
cso30:i:CC_Cell_WithoutCellWall_
--
csml-variable:Double
m137
0
infinite
0
--
p50:RelA-p65{p}{Ac}
--
e136
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m138
10
infinite
0
TRANSPATH | MO000016632 |
--
csml-variable:Double
m139
0
infinite
0
--
ECS:COMMD1
--
e138
cso30:c:Complex
cso30:i:CC_Cell
--
csml-variable:Double
m140
0
infinite
0
--
p65-RelA:p50:SOCS-1
--
e139
cso30:c:Complex
cso30:i:CC_Cell
--
--
csml-variable:Double
m141
0
infinite
0
--
IL-1R
--
e14
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
p50{ub}:RelA-p65{p}
--
e140
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m142
10
infinite
0
TRANSPATH | MO000016632 |
--
PIAS1{p}
--
e141
cso30:c:Protein
cso30:i:CC_Cell
--
csml-variable:Double
m143
0
infinite
0
--
DNA
--
e142
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m144
0
infinite
0
--
p50:RelA-p65{p}:promoter
--
e143
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m145
0
infinite
0
--
RelA-p65:RelA-p65
--
e144
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m146
10
infinite
0
TRANSPATH | MO000016632 |
--
csml-variable:Double
m147
0
infinite
0
--
E2F1
--
e146
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m148
0
infinite
0
--
E2F1:p50:relA-p65{p}
--
e147
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m149
0
infinite
0
--
Il-1beta
--
e148
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m150
0
infinite
0
--
E2F1:p50:RelA-p65{p}:Il-1beta
--
e149
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m151
0
infinite
0
--
IKK{active}
--
e15
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m15
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
csml-variable:Double
m152
0
infinite
0
--
E2F1:p50:relA-p65{p]:TNF
--
e151
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m153
0
infinite
0
--
csml-variable:Double
m154
0
infinite
0
--
E2F1:p50:relA-p65{p}:CCL3
--
e153
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m155
0
infinite
0
--
TNF
--
e154
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m156
0
infinite
0
--
CCL3
--
e155
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m157
0
infinite
0
--
p50:RelA-p65:IkappaB-alpha{p}{ub}
--
e16
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16
10
infinite
0
TRANSPATH | MO000000254 |
--
Proteosome degradants
--
e17
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
csml-variable:Double
m17
0
infinite
0
--
p50:RelA-p65{p}
--
e18
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m18
10
infinite
0
TRANSPATH | MO000016632 |
--
LT alphabeta:receptor
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
CD40L:receptor
--
e20
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m20
0
infinite
0
--
BAFF
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m21
0
infinite
0
--
NIK{active}
--
e22
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m22
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000203 |
--
IKK-alpha{active}
--
e24
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m24
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
TPL-2{active}
--
e33
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
p50:p50
--
e35
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m36
10
infinite
0
TRANSPATH | MO000016632 |
--
Target genes
--
e36
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m37
0
infinite
0
--
TCR
--
e37
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m38
0
infinite
0
--
TCR:CD28
--
e38
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
Carma1:Bcl10:MALT1
--
e39
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
Carma1:Bcl10:MALT1:Ubc13:Uev1
--
e40
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m41
0
infinite
0
--
IKK-alpha:IKK-beta:Nemo{ub}
--
e41
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m42
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
Carma1:Bcl10{ub}:MALT1{ub}:Ubc13:Uev1
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
Carma1:Bcl10{ub}:MALT1{ub}:Ubc13:Uev1:IK{Kub}:TAK1{active}:TAK2:TAB1
--
e43
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
TAK1:TAK2:TAB1
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m45
0
infinite
0
--
Carma1:Bcl10{ub}:MALT1{ub}:Ubc13:Uev1:IKK{ub}{p}:TAK1{active}:TAK2:TAB1
--
e45
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
IKK-alpha:IKK-beta:Nemo{ub}:CYLD
--
e46
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m47
0
infinite
0
--
TRAF2{ub}
--
e47
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m48
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000209 |
--
TRAF6{ub}
--
e48
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m49
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
RIP1{ub}
--
e49
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m64
10
infinite
0
InterPro | IPR000198 |
TRANSPATH | MO000000065 |
--
LPS:TLR4
--
e5
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
TNF:TNFR
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
RIP1:TAK1:TAB1:TAB2:IKK
--
e63
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
RIP1:TAK1{active}:TAB1:TAB2:IKK{active}
--
e64
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m66
0
infinite
0
--
DNA damaging agents
--
e65
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m67
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
TAX1BP1
--
e72
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m74
0
infinite
0
--
A20:TAX1BP1
--
e73
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m75
0
infinite
0
--
A20:TAX1BP1:Itch
--
e74
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m76
0
infinite
0
--
TRAF2:TRAF3
--
e78
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m80
0
infinite
0
--
c-IAP1
--
e79
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m81
0
infinite
0
--
ECS
--
e8
cso30:c:Protein
cso30:i:CC_Cell
--
csml-variable:Double
m8
0
infinite
0
--
TRAF2:TRAF3:c-IAP1
--
e80
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m82
0
infinite
0
--
TRAF2:TRAF3:c-IAP1:NIK
--
e81
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m83
0
infinite
0
--
c-IAP2
--
e82
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m84
0
infinite
0
--
TRAF2:TRAF3:c-IAP2
--
e83
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m85
0
infinite
0
--
TRAF2:TRAF3:c-IAP2:NIK
--
e84
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m86
0
infinite
0
--
TRAF2:TRAF3:c-IAP2:NIK{ub}
--
e85
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m87
0
infinite
0
--
TRAF2:TRAF3:c-IAP1:NIK{ub}
--
e86
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m88
0
infinite
0
--
TWEAK
--
e87
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m89
0
infinite
0
--
TRAF2:TRAF3:NIK{ub}
--
e88
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m90
0
infinite
0
--
c-IAP2:NIK{ub}
--
e89
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m91
0
infinite
0
--
PKA
--
e9
cso30:c:Protein
cso30:i:CC_Cell_WithoutCellWall_
--
csml-variable:Double
m9
0
infinite
0
--
c-IAP2:NIK{ub}
--
e90
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m92
0
infinite
0
--
IRAK:TRAF6
--
e91
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m93
0
infinite
0
--
IRAK{ub}:TRAF6
--
e92
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m94
0
infinite
0
--
IRAK{ub}:TRAF6:IKK
--
e93
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m95
0
infinite
0
--
csml-variable:Double
m96
0
infinite
0
--
k63 ubiquitinated protein
--
e95
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m97
0
infinite
0
--
ABIN-1:k63 ubiquitinated protein
--
e96
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m98
0
infinite
0
--
csml-variable:Double
m99
0
infinite
0
--
ABIN-2:k63 ubiquitinated protein
--
e98
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m100
0
infinite
0
--
csml-variable:Double
m101
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 18775672 This so-called canonical NF-KappaB pathway is stimulated by various immune receptors, such as the Toll-like receptors (TLRs), interleukin-1 receptor (IL-1R), tumor necrosis factor receptor (TNFR) and antigen receptors. PMID: 18775672 The canonical pathway is activated by a large number of agonists [e.g. tumor necrosis fator (TNF), interleukin 1 (IL-1) or microbial ligands such as lipopolysaccharide (LPS)] through the triggering of various cytokine receptors or TLRs and stimulate the IKappaB kinase (IKK) complex (IKK1-IKK2-NEMO) to phosphorylate IKappaB-alpha and promote its degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c283 : 1
stoichiometry:c28 : 1
m10*0.1
nodelay
--
0
PMID: 18775672 Activated IKK phosphorylates IKappaB-alpha, predominantly via the action of IKK2, triggering its lysine-48?linked polyubiquitination and proteasomal degradation, releasing associated NF-KappaB subunits to translocate into the nucleus.
p98
p100
cso30:i:ME_Phosphorylation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c287 : 1
stoichiometry:c288 : 1
stoichiometry:c289 : 1
m114*m1617*0.1
nodelay
--
0
PMID: 18775672 S276 can be phosphorylated by protein kinase A (PKA) and mitogen- and stress-activated protein kinases (MSKs) 1 and 2, inducing binding to CREB-binding protein (CBP) and p300 co-activator complexes, which acetylate adjacent histones and RelA to stimulate target gene transcription. PMID: 18775672 Figure 3
p101
p101
cso30:i:ME_Phosphorylation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c290 : 1
stoichiometry:c291 : 1
stoichiometry:c292 : 1
m15*m115*0.1
nodelay
--
0
PMID: 18775672 IkappaB kinase 1 (IKK1)phosphorylation of CBP-p300 stimulates preferential binding to NF-KappaB complexes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c293 : 1
stoichiometry:c294 : 1
stoichiometry:c295 : 1
m116*m18*0.1
nodelay
--
0
PMID: 18775672 S276 can be phosphorylated by protein kinase A (PKA) and mitogen- and stress-activated protein kinases (MSKs) 1 and 2, inducing binding to CREB-binding protein (CBP) and p300 co-activator complexes, which acetylate adjacent histones and RelA to stimulate target gene transcription
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c296 : 1
stoichiometry:c297 : 1
m117*0.1
nodelay
--
0
PMID: 18775672 S276 can be phosphorylated by protein kinase A (PKA) and mitogen- and stress-activated protein kinases (MSKs) 1 and 2, inducing binding to CREB-binding protein (CBP) and p300 co-activator complexes, which acetylate adjacent histones and RelA to stimulate target gene transcription
p104
p104
cso30:i:ME_Binding
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c298 : 1
stoichiometry:c299 : 1
stoichiometry:c300 : 1
m118*m119*0.1
nodelay
--
0
PMID: 18775672 RelA S276 phosphorylation also triggers recruitment of a complex of CDK1 and cyclin T1, which promotes transcriptional elongation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c301 : 1
stoichiometry:c302 : 1
m118*0.1
nodelay
--
0
PMID: 18775672 RelA S276 phosphorylation also triggers recruitment of a complex of CDK1 and cyclin T1, which promotes transcriptional elongation. PMID: 18775672 Figure 3
p106
p106
cso30:i:ME_Translocation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c303 : 1
stoichiometry:c304 : 1
m71*0.1
nodelay
--
0
PMID: 18775672 NF-KappaB dimers can be transported back to the cytoplasm as a result of NF-KappaB?dependent IKappaBalpha resynthesis.
p106
p107
cso30:i:ME_Translocation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c305 : 1
stoichiometry:c306 : 1
m112*0.1
nodelay
--
0
PMID: 18775672 NF-KappaB dimers can be transported back to the cytoplasm as a result of NF-KappaB?dependent IKappaBalpha resynthesis.
p106
p108
cso30:i:ME_Translocation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c307 : 1
stoichiometry:c308 : 1
m28*0.1
nodelay
--
0
PMID: 18775672 NF-KappaB dimers can be transported back to the cytoplasm as a result of NF-KappaB?dependent IKappaBalpha resynthesis.
p106
p109
cso30:i:ME_Translocation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c309 : 1
stoichiometry:c310 : 1
m18*0.1
nodelay
--
0
PMID: 18775672 NF-KappaB dimers can be transported back to the cytoplasm as a result of NF-KappaB?dependent IKappaBalpha resynthesis.
p11
p11
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c31 : 1
stoichiometry:c30 : 1
m19*m174*0.1
nodelay
--
0
PMID:18775672 The p100-mediated pathway, often called the noncanonical NF-KappaB pathway, is triggered by a subset of TNF family members and sequentially activates NF-KappaB inducing kinase (NIK) and IKK1. PMID: 18775672 A limited number of agonists induce processing of p100 to p52 via activation of NF-KappaB?inducing kinase (NIK) and IKK1, resulting in the nuclear translocation of p52-RelB heterodimers. PMID: 18775672 Figure 1
p106
p110
cso30:i:ME_Translocation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c311 : 1
stoichiometry:c312 : 1
m36*0.1
nodelay
--
0
PMID: 18775672 NF-KappaB dimers can be transported back to the cytoplasm as a result of NF-KappaB?dependent IKappaBalpha resynthesis.
p111
p111
cso30:i:ME_Translation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c313 : 1
stoichiometry:c314 : 1
stoichiometry:c315 : 1
m1617*m126*0.1
nodelay
--
0
PMID: 18775672 NF-KappaB dimers can be transported back to the cytoplasm as a result of NF-KappaB?dependent IKappaBalpha resynthesis.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c316 : 1
stoichiometry:c317 : 1
stoichiometry:c318 : 1
m8*m18*0.1
nodelay
--
0
PMID: 18775672 Alternatively, RelA can be ubiquitinated by ECSSOCS1 or PDLIM2 E3 ligases, triggering its degradation by the proteasome.
p112
p113
cso30:i:ME_Ubiquitination
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c319 : 1
stoichiometry:c320 : 1
stoichiometry:c321 : 1
m128*m18*0.1
nodelay
--
0
PMID: 18775672 Alternatively, RelA can be ubiquitinated by ECSSOCS1 or PDLIM2 E3 ligases, triggering its degradation by the proteasome.
p114
p114
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c322 : 1
stoichiometry:c323 : 1
m127*0.1
nodelay
--
0
PMID: 18775672 Alternatively, RelA can be ubiquitinated by ECSSOCS1 or PDLIM2 E3 ligases, triggering its degradation by the proteasome.
p115
p115
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c324 : 1
stoichiometry:c326 : 1
stoichiometry:c325 : 1
m165*m6*0.1
nodelay
--
0
PMID: 18775672 c-Rel?mediated transcription is also turned off by ubiquitin-dependent proteolysis in stimulated cells
p116
p116
cso30:i:ME_Ubiquitination
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c327 : 1
stoichiometry:c328 : 1
m165*0.1
nodelay
--
0
PMID: 18775672 c-Rel?mediated transcription is also turned off by ubiquitin-dependent proteolysis in stimulated cells
p117
p117
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c329 : 1
stoichiometry:c330 : 1
m130*0.1
nodelay
--
0
PMID: 18775672 c-Rel?mediated transcription is also turned off by ubiquitin-dependent proteolysis in stimulated cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c331 : 1
stoichiometry:c332 : 1
stoichiometry:c333 : 1
m6*m1617*0.1
nodelay
--
0
PMID: 18775672 Binding of phospho-S276-RelA is primarily restricted to a subset of genes that are rapidly induced by TNF, such as the chemokine IL-8. PMID: 18775672 Induction of such genes involves the association of phospho-S276-RelA with the P-TEFb transcriptional elongation factor, a complex of CDK-9 (cyclin-dependent kinase-9) and cyclin T1, which controls Pol II recruitment and activation.
p119
p119
cso30:i:ME_UnknownActivation
cso30:i:CC_Cell
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c339 : 1
stoichiometry:c340 : 1
stoichiometry:c341 : 1
m2269*m2276*0.1
nodelay
--
0
PMID: 18775672,17268554 For example, in epithelial cells, TGF-beta1 induces RelA acetylation on K221 via a Smad3 and 4?PKA?p300-dependent signaling pathway
p11
p12
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m20*m174*0.1
nodelay
--
0
PMID:18775672 The p100-mediated pathway, often called the noncanonical NF-KappaB pathway, is triggered by a subset of TNF family members and sequentially activates NF-KappaB inducing kinase (NIK) and IKK1. PMID: 18775672 A limited number of agonists induce processing of p100 to p52 via activation of NF-KappaB?inducing kinase (NIK) and IKK1, resulting in the nuclear translocation of p52-RelB heterodimers. PMID: 18775672 Figure 1
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c334 : 1
stoichiometry:c335 : 1
stoichiometry:c336 : 1
m18*m131*0.1
nodelay
--
0
PMID: 18775672 Binding of phospho-S276-RelA is primarily restricted to a subset of genes that are rapidly induced by TNF, such as the chemokine IL-8. PMID: 18775672 Induction of such genes involves the association of phospho-S276-RelA with the P-TEFb transcriptional elongation factor, a complex of CDK-9 (cyclin-dependent kinase-9) and cyclin T1, which controls Pol II recruitment and activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c337 : 1
stoichiometry:c338 : 1
m132*0.1
nodelay
--
0
--
p119
p122
cso30:i:ME_UnknownActivation
cso30:i:CC_Cell
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c342 : 1
stoichiometry:c343 : 1
stoichiometry:c344 : 1
m2269*m135*0.1
nodelay
--
0
PMID: 18775672,17268554 For example, in epithelial cells, TGF-beta1 induces RelA acetylation on K221 via a Smad3 and 4?PKA?p300-dependent signaling pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c345 : 1
stoichiometry:c346 : 1
stoichiometry:c347 : 1
m134*m9*0.1
nodelay
--
0
PMID: 18775672,17268554 For example, in epithelial cells, TGF-beta1 induces RelA acetylation on K221 via a Smad3 and 4?PKA?p300-dependent signaling pathway
p119
p124
cso30:i:ME_UnknownActivation
cso30:i:CC_Cell
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c348 : 1
stoichiometry:c350 : 1
stoichiometry:c349 : 1
m2280*m9*0.1
nodelay
--
0
PMID: 18775672,17268554 For example, in epithelial cells, TGF-beta1 induces RelA acetylation on K221 via a Smad3 and 4?PKA?p300-dependent signaling pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c351 : 1
stoichiometry:c352 : 1
stoichiometry:c353 : 1
m136*m115*0.1
nodelay
--
0
PMID: 18775672,17268554 For example, in epithelial cells, TGF-beta1 induces RelA acetylation on K221 via a Smad3 and 4?PKA?p300-dependent signaling pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c354 : 1
stoichiometry:c355 : 1
stoichiometry:c356 : 1
m137*m18*0.1
nodelay
--
0
PMID: 18775672,17268554 For example, in epithelial cells, TGF-¦Â1 induces RelA acetylation on K221 via a Smad3 and 4?PKA?p300-dependent signaling pathway
p127
p127
cso30:i:ME_Ubiquitination
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c364 : 1
stoichiometry:c366 : 1
stoichiometry:c369 : 1
stoichiometry:c365 : 1
m18*m5*0.1
nodelay
--
0
PMID: 18775672,17673665 LPS stimulation of macrophages also increases the ubiquitination and proteolysis of p50 by the proteasome PMID: 18775672 This is inhibited by BCL3, which blocks p50 ubiquitination and stabilizes a p50 complex that inhibits gene transcription.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c357 : 1
stoichiometry:c358 : 1
stoichiometry:c359 : 1
m139*m8*0.1
nodelay
--
0
PMID: 18775672,17183367 COMMD1 interacts with ECSSOCS1 and increases the interaction between SOCS1 and RelA
p129
p129
cso30:i:ME_Binding
cso30:i:CC_Cell
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c360 : 1
stoichiometry:c361 : 1
stoichiometry:c362 : 1
stoichiometry:c363 : 1
m1617*m1906*m140*0.1
nodelay
--
0
PMID: 18775672,17183367 COMMD1 interacts with ECSSOCS1 and increases the interaction between SOCS1 and RelA
p11
p13
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
stoichiometry:c37 : 1
m21*m174*0.1
nodelay
--
0
PMID:18775672 The p100-mediated pathway, often called the noncanonical NF-KappaB pathway, is triggered by a subset of TNF family members and sequentially activates NF-KappaB inducing kinase (NIK) and IKK1. PMID: 18775672 A limited number of agonists induce processing of p100 to p52 via activation of NF-KappaB?inducing kinase (NIK) and IKK1, resulting in the nuclear translocation of p52-RelB heterodimers. PMID: 18775672 Figure 1
p130
p130
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c367 : 1
stoichiometry:c368 : 1
m142*0.1
nodelay
--
0
PMID: 18775672,17673665 LPS stimulation of macrophages also increases the ubiquitination and proteolysis of p50 by the proteasome
p131
p131
cso30:i:ME_Phosphorylation
cso30:i:CC_Cell
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c370 : 1
stoichiometry:c372 : 1
stoichiometry:c371 : 1
m2460*m6*0.1
nodelay
--
0
PMID: 18775672,17540171 After TNF or LPS stimulation, PIAS1 is rapidly phosphorylated on S90, which is required for PIAS1 to block the promoter binding of RelA
p131
p132
cso30:i:ME_Phosphorylation
cso30:i:CC_Cell
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c373 : 1
stoichiometry:c374 : 1
stoichiometry:c375 : 1
m5*m2460*0.1
nodelay
--
0
PMID: 18775672,17540171 After TNF or LPS stimulation, PIAS1 is rapidly phosphorylated on S90, which is required for PIAS1 to block the promoter binding of RelA
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c377 : 1
stoichiometry:c376 : 1
stoichiometry:c379 : 1
stoichiometry:c378 : 1
m144*m18*0.1
nodelay
--
0
PMID: 18775672,17540171 After TNF or LPS stimulation, PIAS1 is rapidly phosphorylated on S90, which is required for PIAS1 to block the promoter binding of RelA
p134
p134
cso30:i:ME_DNABinding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c380 : 1
stoichiometry:c381 : 1
stoichiometry:c383 : 1
stoichiometry:c382 : 1
m18*m144*m44464*0.1
nodelay
--
0
PMID: 18775672,18045535 A partner of RelA, the ribosomal protein S3 (RPS3), was identified by affinity purification and shown to substantially increase the DNA binding activity of RelA-RelA homodimers and p50-RelA heterodimers.
p134
p135
cso30:i:ME_DNABinding
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c384 : 1
stoichiometry:c385 : 1
stoichiometry:c387 : 1
stoichiometry:c386 : 1
m146*m144*m44464*0.1
nodelay
--
0
PMID: 18775672,18045535 A partner of RelA, the ribosomal protein S3 (RPS3), was identified by affinity purification and shown to substantially increase the DNA binding activity of RelA-RelA homodimers and p50-RelA heterodimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c388 : 1
stoichiometry:c389 : 1
stoichiometry:c390 : 1
m148*m18*0.1
nodelay
--
0
PMID: 18775672 E2F1 is rapidly recruited to the promoters of these genes via its physical interaction with p50-RelA heterodimers in LPS-stimulated cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c391 : 1
stoichiometry:c392 : 1
stoichiometry:c393 : 1
m149*m150*0.1
nodelay
--
0
PMID: 18775672 RNAi knockdown revealed a requirement for E2F1 for the transcriptional activation of several LPS-inducible NF-KappaB target genes, including IL-1beta, TNF and CCL3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c394 : 1
stoichiometry:c395 : 1
stoichiometry:c396 : 1
m149*m152*0.1
nodelay
--
0
PMID: 18775672 RNAi knockdown revealed a requirement for E2F1 for the transcriptional activation of several LPS-inducible NF-KappaB target genes, including IL-1beta, TNF and CCL3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c397 : 1
stoichiometry:c398 : 1
stoichiometry:c399 : 1
m154*m149*0.1
nodelay
--
0
PMID: 18775672 RNAi knockdown revealed a requirement for E2F1 for the transcriptional activation of several LPS-inducible NF-KappaB target genes, including IL-1beta, TNF and CCL3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m22*m23*0.1
nodelay
--
0
PMID:18775672 The p100-mediated pathway, often called the noncanonical NF-KappaB pathway, is triggered by a subset of TNF family members and sequentially activates NF-KappaB inducing kinase (NIK) and IKK1. PMID: 18775672 A limited number of agonists induce processing of p100 to p52 via activation of NF-KappaB?inducing kinase (NIK) and IKK1, resulting in the nuclear translocation of p52-RelB heterodimers.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c400 : 1
stoichiometry:c401 : 1
m151*0.1
nodelay
--
0
PMID: 18775672 RNAi knockdown revealed a requirement for E2F1 for the transcriptional activation of several LPS-inducible NF-KappaB target genes, including IL-1beta, TNF and CCL3. PMID: 18775672 E2F1 is rapidly recruited to the promoters of these genes via its physical interaction with p50-RelA heterodimers in LPS-stimulated cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c402 : 1
stoichiometry:c403 : 1
m153*0.1
nodelay
--
0
PMID: 18775672 RNAi knockdown revealed a requirement for E2F1 for the transcriptional activation of several LPS-inducible NF-KappaB target genes, including IL-1beta, TNF and CCL3. PMID: 18775672 E2F1 is rapidly recruited to the promoters of these genes via its physical interaction with p50-RelA heterodimers in LPS-stimulated cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c404 : 1
stoichiometry:c405 : 1
m155*0.1
nodelay
--
0
PMID: 18775672 RNAi knockdown revealed a requirement for E2F1 for the transcriptional activation of several LPS-inducible NF-KappaB target genes, including IL-1beta, TNF and CCL3. PMID: 18775672 E2F1 is rapidly recruited to the promoters of these genes via its physical interaction with p50-RelA heterodimers in LPS-stimulated cells.
p15
p15
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c41 : 1
stoichiometry:c43 : 1
m167*m24*0.1
nodelay
--
0
PMID: 18775672,15214841 IKK1 phosphorylates p100, triggering its polyubiquitination and subsequent partial proteolysis by the proteasome to produce p52, which translocates into the nucleus predominantly in association with RelB PMID: 18775672,11239468,16303288 IKK1 phosphorylates p100 at two C-terminal serines, which promotes p100 ubiquitination by the SCFbetaTrCP ubiquitin E3 ligase, partial proteolysis by the proteasome and subsequent nuclear translocation of p52-RelB complexes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c233 : 1
stoichiometry:c45 : 1
m25*m106*0.1
nodelay
--
0
PMID: 18775672,15214841 IKK1 phosphorylates p100, triggering its polyubiquitination and subsequent partial proteolysis by the proteasome to produce p52, which translocates into the nucleus predominantly in association with RelB PMID: 18775672,11239468,16303288 IKK1 phosphorylates p100 at two C-terminal serines, which promotes p100 ubiquitination by the SCFbetaTrCP ubiquitin E3 ligase, partial proteolysis by the proteasome and subsequent nuclear translocation of p52-RelB complexes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c48 : 1
m26*0.1
nodelay
--
0
PMID: 18775672,15214841 IKK1 phosphorylates p100, triggering its polyubiquitination and subsequent partial proteolysis by the proteasome to produce p52, which translocates into the nucleus predominantly in association with RelB PMID: 18775672,11239468,16303288 IKK1 phosphorylates p100 at two C-terminal serines, which promotes p100 ubiquitination by the SCFbetaTrCP ubiquitin E3 ligase, partial proteolysis by the proteasome and subsequent nuclear translocation of p52-RelB complexes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m27*0.1
nodelay
--
0
PMID: 18775672,15214841 IKK1 phosphorylates p100, triggering its polyubiquitination and subsequent partial proteolysis by the proteasome to produce p52, which translocates into the nucleus predominantly in association with RelB PMID: 18775672,11239468,16303288 IKK1 phosphorylates p100 at two C-terminal serines, which promotes p100 ubiquitination by the SCFbetaTrCP ubiquitin E3 ligase, partial proteolysis by the proteasome and subsequent nuclear translocation of p52-RelB complexes
p19
p19
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c56 : 1
stoichiometry:c52 : 1
m15*m31*0.1
nodelay
--
0
PMID: 18775672 However, p105 is phosphorylated by IKK after activation of the canonical pathway, targeting it for complete degradation by the proteasome to release associated NF-KappaB subunits. PMID: 18775672 By contrast, the canonical IKK complex triggers p105 proteolysis, which releases associated Rel subunits and also facilitates activation of the p105-associated TPL-2 MEK kinase, which triggers extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m185*m14*0.1
nodelay
--
0
PMID: 18775672 The canonical pathway is activated by a large number of agonists [e.g. tumor necrosis fator (TNF), interleukin 1 (IL-1) or microbial ligands such as lipopolysaccharide (LPS)] through the triggering of various cytokine receptors or TLRs and stimulate the IKappaB kinase (IKK) complex (IKK1-IKK2-NEMO) to phosphorylate IKappaB-alpha and promote its degradation. PMID: 18775672 This so-called canonical NF-KappaB pathway is stimulated by various immune receptors, such as the Toll-like receptors (TLRs), interleukin-1 receptor (IL-1R), tumor necrosis factor receptor (TNFR) and antigen receptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m15*m29*0.1
nodelay
--
0
PMID: 18775672 However, p105 is phosphorylated by IKK after activation of the canonical pathway, targeting it for complete degradation by the proteasome to release associated NF-KappaB subunits. PMID: 18775672 By contrast, the canonical IKK complex triggers p105 proteolysis, which releases associated Rel subunits and also facilitates activation of the p105-associated TPL-2 MEK kinase, which triggers extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase activation
p21
p21
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c54 : 1
stoichiometry:c55 : 1
m171*0.1
nodelay
--
0
PMID: 18775672 By contrast, the canonical IKK complex triggers p105 proteolysis, which releases associated Rel subunits and also facilitates activation of the p105-associated TPL-2 MEK kinase, which triggers extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase activation PMID: 18775672 However, p105 is phosphorylated by IKK after activation of the canonical pathway, targeting it for complete degradation by the proteasome to release associated NF-KappaB subunits
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m32*0.1
nodelay
--
0
PMID: 18775672 By contrast, the canonical IKK complex triggers p105 proteolysis, which releases associated Rel subunits and also facilitates activation of the p105-associated TPL-2 MEK kinase, which triggers extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase activation PMID: 18775672 However, p105 is phosphorylated by IKK after activation of the canonical pathway, targeting it for complete degradation by the proteasome to release associated NF-KappaB subunits
p23
p23
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m33*m34*0.1
nodelay
--
0
PMID: 18775672 By contrast, the canonical IKK complex triggers p105 proteolysis, which releases associated Rel subunits and also facilitates activation of the p105-associated TPL-2 MEK kinase, which triggers extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m30*0.1
nodelay
--
0
PMID: 18775672 Figure1
p25
p25
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c278 : 1
stoichiometry:c279 : 1
stoichiometry:c69 : 1
m28*0.1
nodelay
--
0
PMID: 18775672 Figure1 PMID: 18775672 In unstimulated cells, homodimers of p50 and p52 actively repress transcription of NF-¦ÊB target genes to which they are bound by recruitment of histone deacetylases (HDAC).
p25
p26
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c280 : 1
stoichiometry:c281 : 1
stoichiometry:c71 : 1
m18*0.1
nodelay
--
0
PMID: 18775672 Figure1
p27
p27
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c276 : 1
stoichiometry:c277 : 1
stoichiometry:c73 : 1
m36*0.1
nodelay
--
0
PMID: 18775672 Figure1 PMID: 18775672 In unstimulated cells, homodimers of p50 and p52 actively repress transcription of NF-¦ÊB target genes to which they are bound by recruitment of histone deacetylases (HDAC).
p28
p28
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c76 : 1
stoichiometry:c75 : 1
m93309*m35*0.1
nodelay
--
0
PMID: 18775672,15214841 Tpl-2 is a mitogen-activated protein (MAP) 3-kinase that mediates TLR-stimulated activation of extracellular signal-regulated kinase (ERK) and production of TNF-alpha in macrophages, thereby regulating inflammatory responses
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
stoichiometry:c79 : 1
m38*m387*0.1
nodelay
--
0
PMID: 18775672 Ligation of TCR and the costimulatory molecule CD28 triggers the association of the intermediate CBM signaling complex, composed of Carma1, Bcl10 and MALT1, with the Ubc13-Uve1 ubiquitin conjugating enzyme heterodimer.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m13*m12*0.1
nodelay
--
0
PMID: 18775672 The canonical pathway is activated by a large number of agonists [e.g. tumor necrosis fator (TNF), interleukin 1 (IL-1) or microbial ligands such as lipopolysaccharide (LPS)] through the triggering of various cytokine receptors or TLRs and stimulate the IKappaB kinase (IKK) complex (IKK1-IKK2-NEMO) to phosphorylate IKappaB-alpha and promote its degradation. PMID: 18775672 This so-called canonical NF-KappaB pathway is stimulated by various immune receptors, such as the Toll-like receptors (TLRs), interleukin-1 receptor (IL-1R), tumor necrosis factor receptor (TNFR) and antigen receptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c80 : 1
stoichiometry:c81 : 1
stoichiometry:c82 : 1
stoichiometry:c83 : 1
m39*m40*m16540*0.1
nodelay
--
0
PMID: 18775672 Ligation of TCR and the costimulatory molecule CD28 triggers the association of the intermediate CBM signaling complex, composed of Carma1, Bcl10 and MALT1, with the Ubc13-Uve1 ubiquitin conjugating enzyme heterodimer PMID: 18775672,17948050 TCR stimulation similarly promotes recruitment of TAK1 and IKK to the paracaspase MALT1, which is conjugated with K63-linked ubiquitin chains
p31
p31
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c84 : 1
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m41*m181*0.1
nodelay
--
0
PMID: 18775672 This mediates K63-linked ubiquitination of NEMO, Bcl10 and MALT1, promoting the interaction of the CBM complex with IKK and transforming growth factor beta (TGF-beta)-activated kinase 1 (TAK1), which is a required step for the activation of IKK. PMID: 18775672 For example, positions K399 and K285 of NEMO are conjugated with K63-linked polyubiquitin chains in cells stimulated via the TCR (T-cell receptor) and NOD2 (nucleotide oligomerization domain), respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m41*0.1
nodelay
--
0
PMID: 18775672 This mediates K63-linked ubiquitination of NEMO, Bcl10 and MALT1, promoting the interaction of the CBM complex with IKK and transforming growth factor beta (TGF-beta)-activated kinase 1 (TAK1), which is a required step for the activation of IKK.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c92 : 1
stoichiometry:c91 : 1
m42*m43*m45*0.1
nodelay
--
0
PMID: 18775672 This mediates K63-linked ubiquitination of NEMO, Bcl10 and MALT1, promoting the interaction of the CBM complex with IKK and transforming growth factor beta (TGF-beta)-activated kinase 1 (TAK1), which is a required step for the activation of IKK. PMID: 18775672 It is generally thought that assembly of ubiquitin-dependent signaling complexes both activates TAK1 and allows TAK1 to efficiently phosphorylate and activate IKK.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m44*0.1
nodelay
--
0
--
p35
p35
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m46*m16910*0.1
nodelay
--
0
PMID: 18775672 Figure 1b
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m19042*m42*0.1
nodelay
--
0
PMID: 18775672,18535581 CYLD physically interacts with and deubiquitinates NEMO, thereby negatively regulating NF-KappaB activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
m47*0.1
nodelay
--
0
PMID: 18775672,18535581 CYLD physically interacts with and deubiquitinates NEMO, thereby negatively regulating NF-KappaB activation
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m6*m180*0.1
nodelay
--
0
PMID: 18775672 On receptor ligation, TRAF2 and TRAF6 undergo self-ubiquitination and induce the ubiquitination of target proteins involved in IKK activation, such as NF-¦ÊB essential modulator (NEMO) and several signaling adaptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c108 : 1
m14*m183*0.1
nodelay
--
0
PMID: 18775672 On receptor ligation, TRAF2 and TRAF6 undergo self-ubiquitination and induce the ubiquitination of target proteins involved in IKK activation, such as NF-¦ÊB essential modulator (NEMO) and several signaling adaptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m5*m181*0.1
nodelay
--
0
PMID: 18775672 On ligand engagement, each of these triggers signal transduction events that lead to the activation of the IKappaB kinase (IKK) complex, composed of two catalytic subunits (IKK1 and IKK2) and a regulatory subunit, NEMO (NF-KappaB essential modulator). PMID: 18775672 By contrast, the canonical IKK complex triggers p105 proteolysis, which releases associated Rel subunits and also facilitates activation of the p105-associated TPL-2 MEK kinase, which triggers extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase activation PMID: 18775672 However, p105 is phosphorylated by IKK after activation of the canonical pathway, targeting it for complete degradation by the proteasome to release associated NF-KappaB subunits.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m49*m181*0.1
nodelay
--
0
PMID: 18775672 On receptor ligation, TRAF2 and TRAF6 undergo self-ubiquitination and induce the ubiquitination of target proteins involved in IKK activation, such as NF-¦ÊB essential modulator (NEMO) and several signaling adaptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m48*m181*0.1
nodelay
--
0
PMID: 18775672 On receptor ligation, TRAF2 and TRAF6 undergo self-ubiquitination and induce the ubiquitination of target proteins involved in IKK activation, such as NF-¦ÊB essential modulator (NEMO) and several signaling adaptors.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m5*m183*0.1
nodelay
--
0
PMID: 18775672 On receptor ligation, TRAF2 and TRAF6 undergo self-ubiquitination and induce the ubiquitination of target proteins involved in IKK activation, such as NF-¦ÊB essential modulator (NEMO) and several signaling adaptors.
p43
p43
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m48*m63*0.1
nodelay
--
0
PMID: 18775672 In TNF-stimulated cells, TRAF2 mediates the K63 ubiquitination of an adaptor kinase, RIP1, which in turn recruits TAK1 and IKK complexes and mediates their catalytic activation.
p44
p44
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c122 : 1
stoichiometry:c123 : 1
stoichiometry:c124 : 1
m63*m45*m181*0.1
nodelay
--
0
PMID: 18775672 In TNF-stimulated cells, TRAF2 mediates the K63 ubiquitination of an adaptor kinase, RIP1, which in turn recruits TAK1 and IKK complexes and mediates their catalytic activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m65*0.1
nodelay
--
0
indirect
p46
p46
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c127 : 1
stoichiometry:c129 : 1
m4947*m181*0.1
nodelay
--
0
PMID: 18775672 For example, positions K399 and K285 of NEMO are conjugated with K63-linked polyubiquitin chains in cells stimulated via the TCR (T-cell receptor) and NOD2 (nucleotide oligomerization domain), respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c130 : 1
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m67*m181*0.1
nodelay
--
0
PMID: 18775672 By contrast, DNA damaging agents induce NEMO monoubiquitination at positions K277 and K309.
p48
p48
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c134 : 1
stoichiometry:c135 : 1
m19042*m49*0.1
nodelay
--
0
PMID: 18775672,18535581 CYLD also removes K63-linked ubiquitin from TRAF2, TRAF6, TRAF7, RIP1, TAK1 and Bcl-3
p48
p49
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c136 : 1
stoichiometry:c137 : 1
stoichiometry:c138 : 1
m19042*m48*0.1
nodelay
--
0
PMID: 18775672,18535581 CYLD also removes K63-linked ubiquitin from TRAF2, TRAF6, TRAF7, RIP1, TAK1 and Bcl-3
p4
p5
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m11*m181*0.1
nodelay
--
0
PMID: 18775672 On ligand engagement, each of these triggers signal transduction events that lead to the activation of the IKappaB kinase (IKK) complex, composed of two catalytic subunits (IKK1 and IKK2) and a regulatory subunit, NEMO (NF-KappaB essential modulator).
p48
p50
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c140 : 1
stoichiometry:c141 : 1
m19042*m68*0.1
nodelay
--
0
PMID: 18775672,18535581 CYLD also removes K63-linked ubiquitin from TRAF2, TRAF6, TRAF7, RIP1, TAK1 and Bcl-3
p48
p51
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c143 : 1
stoichiometry:c144 : 1
m19042*m64*0.1
nodelay
--
0
PMID: 18775672,18535581 CYLD also removes K63-linked ubiquitin from TRAF2, TRAF6, TRAF7, RIP1, TAK1 and Bcl-3
p48
p52
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c146 : 1
stoichiometry:c147 : 1
m19042*m204*0.1
nodelay
--
0
PMID: 18775672,18535581 CYLD also removes K63-linked ubiquitin from TRAF2, TRAF6, TRAF7, RIP1, TAK1 and Bcl-3
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c148 : 1
stoichiometry:c149 : 1
m204*0.1
nodelay
--
0
PMID: 18775672,16713561 Bcl-3 ubiquitination, by contrast, seems to promote its translocation into the nucleus, where it functions as a transcriptional coactivator of p50- and p52-containing complexes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c151 : 1
stoichiometry:c152 : 1
m70*m71*0.1
nodelay
--
0
PMID: 18775672,16713561 Bcl-3 ubiquitination, by contrast, seems to promote its translocation into the nucleus, where it functions as a transcriptional coactivator of p50- and p52-containing complexes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c254 : 1
stoichiometry:c255 : 1
m105*0.1
nodelay
--
0
PMID: 18775672,15334086,18342009,14748687,15258597,16684768 Like CYLD, A20 can deubiquitinate several NF-¦ÊB regulatory proteins, including TRAF6, RIP1, RIP2 and NEMO
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c160 : 1
m103*0.1
nodelay
--
0
PMID: 18775672,15334086,18342009,14748687,15258597,16684768 Like CYLD, A20 can deubiquitinate several NF-¦ÊB regulatory proteins, including TRAF6, RIP1, RIP2 and NEMO
p55
p57
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c155 : 1
stoichiometry:c159 : 1
m1585*m73*0.1
nodelay
--
0
PMID: 18775672,15334086,18342009,14748687,15258597,16684768 Like CYLD, A20 can deubiquitinate several NF-¦ÊB regulatory proteins, including TRAF6, RIP1, RIP2 and NEMO
p55
p58
cso30:i:ME_Deubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c163 : 1
stoichiometry:c164 : 1
m1585*m42*0.1
nodelay
--
0
PMID: 18775672,15334086,18342009,14748687,15258597,16684768 Like CYLD, A20 can deubiquitinate several NF-¦ÊB regulatory proteins, including TRAF6, RIP1, RIP2 and NEMO
p59
p59
cso30:i:ME_Ubiquitination
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c165 : 1
stoichiometry:c167 : 1
m63*m1585*0.1
nodelay
--
0
PMID: 18775672 A20 removes K63-linked ubiquitin chains from RIP1 and concurrently stimulates conjugation of K48-linked ubiquitin chains to RIP1, which targets it for proteasomal degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m6*m181*0.1
nodelay
--
0
PMID: 18775672 On ligand engagement, each of these triggers signal transduction events that lead to the activation of the IKappaB kinase (IKK) complex, composed of two catalytic subunits (IKK1 and IKK2) and a regulatory subunit, NEMO (NF-KappaB essential modulator). PMID: 18775672 By contrast, the canonical IKK complex triggers p105 proteolysis, which releases associated Rel subunits and also facilitates activation of the p105-associated TPL-2 MEK kinase, which triggers extracellular signal-regulated kinase (ERK) mitogen-activated protein (MAP) kinase activation PMID: 18775672 However, p105 is phosphorylated by IKK after activation of the canonical pathway, targeting it for complete degradation by the proteasome to release associated NF-KappaB subunits.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c168 : 1
stoichiometry:c169 : 1
m64*0.1
nodelay
--
0
PMID: 18775672 A20 removes K63-linked ubiquitin chains from RIP1 and concurrently stimulates conjugation of K48-linked ubiquitin chains to RIP1, which targets it for proteasomal degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c170 : 1
stoichiometry:c171 : 1
stoichiometry:c172 : 1
m1585*m74*0.1
nodelay
--
0
PMID: 18775672,18246070 However, it is uncertain whether the E3 ligase activity associated with A20 is intrinsic, because Itch E3 ligase can be recruited to A20 via TAX1BP1 (TAX1-binding protein 1), an adaptor that was originally found to associate with the Tax protein encoded by human T-cell leukemia virus type I PMID: 18775672,17703191,18239685 TAX1BP1 interacts with A20 and mediates the recruitment of A20 to K63-ubiquitinated RIP1 and TRAF6
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c173 : 1
stoichiometry:c174 : 1
stoichiometry:c175 : 1
m75*m16459*0.1
nodelay
--
0
PMID: 18775672,18246070 However, it is uncertain whether the E3 ligase activity associated with A20 is intrinsic, because Itch E3 ligase can be recruited to A20 via TAX1BP1 (TAX1-binding protein 1), an adaptor that was originally found to associate with the Tax protein encoded by human T-cell leukemia virus type I
p63
p63
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c176 : 1
stoichiometry:c177 : 1
stoichiometry:c178 : 1
m15*m1585*0.1
nodelay
--
0
PMID: 18775672,17709380 The DUB catalytic activity of A20 might also be positively regulated through its phosphorylation by IKK2
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c187 : 1
stoichiometry:c188 : 1
stoichiometry:c189 : 1
m81*m80*0.1
nodelay
--
0
PMID: 18775672 TNF receptor?associated factor 2 (TRAF2) and TRAF3 physically associate with cellular inhibitor of apoptosis 1 (c-IAP1; or c-IAP2) and NIK, respectively, and form a NIK-degradation complex via TRAF2-TRAF3 dimerization.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c190 : 1
stoichiometry:c191 : 1
stoichiometry:c192 : 1
m174*m82*0.1
nodelay
--
0
PMID: 18775672 TNF receptor?associated factor 2 (TRAF2) and TRAF3 physically associate with cellular inhibitor of apoptosis 1 (c-IAP1; or c-IAP2) and NIK, respectively, and form a NIK-degradation complex via TRAF2-TRAF3 dimerization.
p69
p69
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c193 : 1
stoichiometry:c194 : 1
stoichiometry:c195 : 1
m1872*m180*0.1
nodelay
--
0
PMID: 18775672 Because TRAF2 dimerizes with TRAF3 and physically interacts with c-IAPs and NIK, an attractive model is that these two TRAF members bridge NIK with its ubiquitin ligases c-IAP1 and 2, and thus both serve as essential components of the NIK-degradation complex.
p7
p7
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m15*m16910*0.1
nodelay
--
0
PMID: 18775672 Figure 1 PMID: 18775672 Activated IKK phosphorylates IKappaB-alpha, predominantly via the action of IKK2, triggering its lysine-48?linked polyubiquitination and proteasomal degradation, releasing associated NF-KappaB subunits to translocate into the nucleus. PMID: 18775672 The canonical pathway is activated by a large number of agonists [e.g. tumor necrosis fator (TNF), interleukin 1 (IL-1) or microbial ligands such as lipopolysaccharide (LPS)] through the triggering of various cytokine receptors or TLRs and stimulate the IKappaB kinase (IKK) complex (IKK1-IKK2-NEMO) to phosphorylate IKappaB-alpha and promote its degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c196 : 1
stoichiometry:c197 : 1
stoichiometry:c198 : 1
m84*m80*0.1
nodelay
--
0
PMID: 18775672 TNF receptor?associated factor 2 (TRAF2) and TRAF3 physically associate with cellular inhibitor of apoptosis 1 (c-IAP1; or c-IAP2) and NIK, respectively, and form a NIK-degradation complex via TRAF2-TRAF3 dimerization.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c199 : 1
stoichiometry:c200 : 1
m174*0.1
nodelay
--
0
PMID: 18775672 TNF receptor?associated factor 2 (TRAF2) and TRAF3 physically associate with cellular inhibitor of apoptosis 1 (c-IAP1; or c-IAP2) and NIK, respectively, and form a NIK-degradation complex via TRAF2-TRAF3 dimerization.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c201 : 1
stoichiometry:c202 : 1
m86*0.1
nodelay
--
0
PMID: 18775672 TNF receptor?associated factor 2 (TRAF2) and TRAF3 physically associate with cellular inhibitor of apoptosis 1 (c-IAP1; or c-IAP2) and NIK, respectively, and form a NIK-degradation complex via TRAF2-TRAF3 dimerization.
p73
p73
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c203 : 1
stoichiometry:c204 : 1
stoichiometry:c205 : 1
m87*0.1
nodelay
--
0
PMID: 18775672 TNF receptor?associated factor 2 (TRAF2) and TRAF3 physically associate with cellular inhibitor of apoptosis 1 (c-IAP1; or c-IAP2) and NIK, respectively, and form a NIK-degradation complex via TRAF2-TRAF3 dimerization.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c206 : 1
stoichiometry:c207 : 1
m83*0.1
nodelay
--
0
PMID: 18775672 TNF receptor?associated factor 2 (TRAF2) and TRAF3 physically associate with cellular inhibitor of apoptosis 1 (c-IAP1; or c-IAP2) and NIK, respectively, and form a NIK-degradation complex via TRAF2-TRAF3 dimerization.
p73
p75
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c208 : 1
stoichiometry:c209 : 1
stoichiometry:c210 : 1
m88*0.1
nodelay
--
0
PMID: 18775672 TNF receptor?associated factor 2 (TRAF2) and TRAF3 physically associate with cellular inhibitor of apoptosis 1 (c-IAP1; or c-IAP2) and NIK, respectively, and form a NIK-degradation complex via TRAF2-TRAF3 dimerization.
p76
p76
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c211 : 1
stoichiometry:c212 : 1
stoichiometry:c213 : 1
stoichiometry:c214 : 1
m89*m88*0.1
nodelay
--
0
PMID: 18775672 Figure2 PMID: 18775672,15084608,18022362,16148124 For example, degradation of c-IAP1 is associated with induction of p100 processing by a TNF family member, TWEAK (TNF-like weak inducer of apoptosis) , whereas TRAF2 and TRAF3 proteolysis is induced by several other agonists of the noncanonical pathway
p77
p77
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c215 : 1
stoichiometry:c216 : 1
stoichiometry:c217 : 1
m90*m181*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c218 : 1
stoichiometry:c219 : 1
stoichiometry:c220 : 1
m89*m87*0.1
nodelay
--
0
PMID: 18775672 Figure2 PMID: 18775672,15084608,18022362,16148124 For example, degradation of c-IAP1 is associated with induction of p100 processing by a TNF family member, TWEAK (TNF-like weak inducer of apoptosis) , whereas TRAF2 and TRAF3 proteolysis is induced by several other agonists of the noncanonical pathway
p79
p79
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c221 : 1
stoichiometry:c222 : 1
stoichiometry:c223 : 1
stoichiometry:c228 : 1
m19*m87*0.1
nodelay
--
0
PMID: 18775672 Figure2 PMID: 18775672,15084608,18022362,16148124 For example, degradation of c-IAP1 is associated with induction of p100 processing by a TNF family member, TWEAK (TNF-like weak inducer of apoptosis) , whereas TRAF2 and TRAF3 proteolysis is induced by several other agonists of the noncanonical pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
m208*0.1
nodelay
--
0
--
p79
p80
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c224 : 1
stoichiometry:c225 : 1
stoichiometry:c226 : 1
stoichiometry:c229 : 1
m88*m19*0.1
nodelay
--
0
PMID: 18775672 Figure2 PMID: 18775672,15084608,18022362,16148124 For example, degradation of c-IAP1 is associated with induction of p100 processing by a TNF family member, TWEAK (TNF-like weak inducer of apoptosis) , whereas TRAF2 and TRAF3 proteolysis is induced by several other agonists of the noncanonical pathway
p79
p81
cso30:i:ME_UnknownDegradation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c227 : 1
stoichiometry:c230 : 1
stoichiometry:c231 : 1
stoichiometry:c232 : 1
m20*m87*0.1
nodelay
--
0
PMID: 18775672 Figure2 PMID: 18775672,15084608,18022362,16148124 For example, degradation of c-IAP1 is associated with induction of p100 processing by a TNF family member, TWEAK (TNF-like weak inducer of apoptosis) , whereas TRAF2 and TRAF3 proteolysis is induced by several other agonists of the noncanonical pathway
p83
p83
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c234 : 1
stoichiometry:c235 : 1
stoichiometry:c239 : 1
stoichiometry:c236 : 1
m184*m183*m5*0.1
nodelay
--
0
PMID: 18775672,17997719,18347055,18180283 However, recent evidence suggests that IRAK1 is conjugated with K63-linked ubiquitin chains and provides a binding platform for IKK and possibly other signaling complexes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c237 : 1
stoichiometry:c238 : 1
m93*0.1
nodelay
--
0
PMID: 18775672,17997719,18347055,18180283 However, recent evidence suggests that IRAK1 is conjugated with K63-linked ubiquitin chains and provides a binding platform for IKK and possibly other signaling complexes
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c240 : 1
stoichiometry:c241 : 1
stoichiometry:c242 : 1
m94*m181*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c243 : 1
stoichiometry:c244 : 1
stoichiometry:c245 : 1
m96*m97*0.1
nodelay
--
0
PMID: 18775672,18212736 The ABIN (A20-binding inhibitor of NF-KappaB) family proteins, ABIN-1, ABIN-2 and ABIN-3, also contain a UBD homologous to that of NEMO and can bind to K63 ubiquitinated proteins
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c246 : 1
stoichiometry:c247 : 1
stoichiometry:c248 : 1
m97*m99*0.1
nodelay
--
0
PMID: 18775672,18212736 The ABIN (A20-binding inhibitor of NF-KappaB) family proteins, ABIN-1, ABIN-2 and ABIN-3, also contain a UBD homologous to that of NEMO and can bind to K63 ubiquitinated proteins
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c249 : 1
stoichiometry:c250 : 1
stoichiometry:c251 : 1
m97*m101*0.1
nodelay
--
0
PMID: 18775672,18212736 The ABIN (A20-binding inhibitor of NF-KappaB) family proteins, ABIN-1, ABIN-2 and ABIN-3, also contain a UBD homologous to that of NEMO and can bind to K63 ubiquitinated proteins
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c156 : 1
stoichiometry:c157 : 1
m75*m64*0.1
nodelay
--
0
PMID: 18775672,17703191,18239685 TAX1BP1 interacts with A20 and mediates the recruitment of A20 to K63-ubiquitinated RIP1 and TRAF6
p9
p9
cso30:i:ME_ProteasomeDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c25 : 1
stoichiometry:c26 : 1
m16*0.1
nodelay
--
0
PMID: 18775672 Activated IKK phosphorylates IKappaB-alpha, predominantly via the action of IKK2, triggering its lysine-48?linked polyubiquitination and proteasomal degradation, releasing associated NF-KappaB subunits to translocate into the nucleus
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c161 : 1
stoichiometry:c252 : 1
stoichiometry:c253 : 1
m75*m49*0.1
nodelay
--
0
PMID: 18775672,17703191,18239685 TAX1BP1 interacts with A20 and mediates the recruitment of A20 to K63-ubiquitinated RIP1 and TRAF6
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c256 : 1
stoichiometry:c260 : 1
stoichiometry:c257 : 1
m81*m108*0.1
nodelay
--
0
PMID: 18775672,18022362,18022363 Synthetic c-IAP antagonists induce rapid degradation of c-IAP1 and c-IAP2 via the ubiquitin-proteasome pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c258 : 1
stoichiometry:c259 : 1
m109*0.1
nodelay
--
0
PMID: 18775672,18022362,18022363 Synthetic c-IAP antagonists induce rapid degradation of c-IAP1 and c-IAP2 via the ubiquitin-proteasome pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c261 : 1
stoichiometry:c262 : 1
stoichiometry:c263 : 1
m108*m84*0.1
nodelay
--
0
PMID: 18775672,18022362,18022363 Synthetic c-IAP antagonists induce rapid degradation of c-IAP1 and c-IAP2 via the ubiquitin-proteasome pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c264 : 1
stoichiometry:c265 : 1
m110*0.1
nodelay
--
0
PMID: 18775672,18022362,18022363 Synthetic c-IAP antagonists induce rapid degradation of c-IAP1 and c-IAP2 via the ubiquitin-proteasome pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c266 : 1
stoichiometry:c267 : 1
stoichiometry:c268 : 1
m36*m7346*0.1
nodelay
--
0
PMID: 18775672 In unstimulated cells, homodimers of p50 and p52 actively repress transcription of NF-¦ÊB target genes to which they are bound by recruitment of histone deacetylases (HDAC).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c269 : 1
stoichiometry:c270 : 1
stoichiometry:c271 : 1
m112*m7346*0.1
nodelay
--
0
PMID: 18775672 In unstimulated cells, homodimers of p50 and p52 actively repress transcription of NF-¦ÊB target genes to which they are bound by recruitment of histone deacetylases (HDAC).
p97
p97
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleolus
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c272 : 1
stoichiometry:c274 : 1
stoichiometry:c275 : 1
stoichiometry:c273 : 1
m71*0.1
nodelay
--
0
PMID: 18775672 Figure 1 PMID: 18775672 In unstimulated cells, homodimers of p50 and p52 actively repress transcription of NF-¦ÊB target genes to which they are bound by recruitment of histone deacetylases (HDAC).
p98
p98
cso30:i:ME_Phosphorylation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c282 : 1
stoichiometry:c27 : 1
m9*m1617*0.1
nodelay
--
0
PMID: 18775672 S276 can be phosphorylated by protein kinase A (PKA) and mitogen- and stress-activated protein kinases (MSKs) 1 and 2, inducing binding to CREB-binding protein (CBP) and p300 co-activator complexes, which acetylate adjacent histones and RelA to stimulate target gene transcription. PMID: 18775672 Figure 3
p98
p99
cso30:i:ME_Phosphorylation
cso30:i:CC_Cell_WithoutCellWall_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c284 : 1
stoichiometry:c285 : 1
stoichiometry:c286 : 1
m3621*m1617*0.1
nodelay
--
0
PMID: 18775672 S276 can be phosphorylated by protein kinase A (PKA) and mitogen- and stress-activated protein kinases (MSKs) 1 and 2, inducing binding to CREB-binding protein (CBP) and p300 co-activator complexes, which acetylate adjacent histones and RelA to stimulate target gene transcription. PMID: 18775672 Figure 3
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--